The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and these patents are valid through 2025, the company said in a filing to the BSE today.
Suven CEO Venkat Jasti said: "We are very pleased by the grant of these pate .
Read more
Suven Life Sciences gets 3 patents in Canada, China, India
Reviewed by GlamourTreat
on
January 31, 2014
Rating:
Reviewed by GlamourTreat
on
January 31, 2014
Rating:
No comments:
Note: Only a member of this blog may post a comment.